Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...

The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading ...

Following a pre-specified interim analysis, the Data Safety Monitoring Board (DSMB) recommended the DRAGON trial, a pivotal Phase 3 trial in ...

About Belite Bio Belite Bio is a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet ...

Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...

The canine is a hound breed developed in mid-19th-century England to chase rabbits for sport in an arena. Whippets were ...

The most expensive pharmaceuticals include Zolgensma, Zokinvy, Danyelza, Luxturna, Ravicti, Myalept, and more.

Each patient received a 50,000-cell suspension of RPESC-RPE-4W implanted under the macula ... of adults affected by dry AMD and geographic atrophy. We look forward to advancing our Phase 1/2a ...

Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration. You may have vision loss that happens over time. Here’s what you can expect. With GA, you get blind spots in ...

Postmenopausal atrophic vaginitis, or vaginal atrophy, is the thinning of the walls of the vagina caused by decreased estrogen levels. This most commonly occurs after menopause. Menopause is the ...

Discover how Apellis Pharmaceuticals, Inc. surpasses Q4 expectations with impressive revenue growth and cost reductions.

Ocugen, Inc. (NASDAQ: OCGN) announced that the European Commission has granted Advanced Therapy Medicinal Product (ATMP) classifications for its gene therapies OCU410 and OCU410ST. This regulatory ...